Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Protein > Her2 > HE2-C52Hb

Cynomolgus Her2 / ErbB2 Protein, His Tag (MALS verified)

Recommended Hot Products:

We offer IHC Antibody Products against multiple biomarker targets with sufficient validation, reliable quality, flexible authorization and service support!

Order Now

  • Synonym
    ERBB2,CD340,HER-2,neu,HER2,MLN19,NEU,NGL,TKR1
  • Source
    Cynomolgus Her2, His Tag(HE2-C52Hb) is expressed from human 293 cells (HEK293). It contains AA Thr 23 - Thr 652 (Accession # XP_005584091.2).
    Predicted N-terminus: Thr 23
  • Molecular Characterization
    Her2 Structure

    This protein carries a polyhistidine tag at the C-terminus

    The protein has a calculated MW of 71.2 kDa. The protein migrates as 85-100 KDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Endotoxin
    Less than 1.0 EU per μg by the LAL method.
  • Purity

    >95% as determined by SDS-PAGE.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
SDS-PAGE
Her2 SDS-PAGE

Cynomolgus Her2, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.

SEC-MALS
Her2 MALS images

The purity of Cynomolgus Her2, His Tag (Cat. No. HE2-C52Hb) is more than 85% and the molecular weight of this protein is around 75-105 kDa verified by SEC-MALS.

Bioactivity-ELISA
 Her2 ELISA

Immobilized Trastuzumab Biosimilar at 2 μg/mL (100 μL/well) can bind Cynomolgus Her2, His Tag (Cat. No. HE2-C52Hb) with a linear range of 1-31 ng/mL (QC tested).

 Her2 ELISA

Immobilized Cynomolgus Her2, His Tag (Cat. No. HE2-C52Hb) at 1 μg/mL (100 μL/well) can bind Bispecific Antibody (Her2 × Her3) with a linear range of 0.1-2 ng/mL (Routinely tested).

 Her2 ELISA

Immobilized Cynomolgus Her2, His Tag (Cat. No. HE2-C52Hb) at 1 μg/mL (100 μL/well) can bind Pertuzumab Biosimilar with a linear range of 0.1-2 ng/mL (Routinely tested).

Bioactivity-BLI
 Her2 BLI

Loaded Hercecptin on AHC Biosensor, can bind Cynomolgus Her2, His Tag (Cat. No. HE2-C52Hb) with an affinity constant of 4.86 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

  • Background
    Human Epidermal growth factor Receptor 2 (HER2) is also called ERBB2, HER-2,HER-2 /neu, NEU, NGL,TKR1 and c-erb B2,and is a protein giving higher aggressiveness in breast cancers. It is a member of the ErbB protein family, more commonly known as the epidermal growth factor receptor family. HER2 is a cell membrane surface-bound receptor tyrosine kinase and is normally involved in the signal transduction pathways leading to cell growth and differentiation. HER2 is thought to be an orphan receptor, with none of the EGF family of ligands able to activate it. Approximately 30% of breast cancers have an amplification of the HER2 gene or overexpression of its protein product. Overexpression of this receptor in breast cancer is associated with increased disease recurrence and worse prognosis. HER2 appears to play roles in development, cancer, communication at the neuromuscular junction and regulation of cell growth and differentiation .
  • Clinical and Translational Updates

Comments (0)


ETA of in-stock products: 2 business days

Price(USD) : $300.00

Price(USD) : $2180.00

Promotion & Exhibitions



Drug Development Status

  • Number of Launched Drugs:34 Details
  • Number of Drugs in Clinical Trials:202 Details
  • Latest Research Phase:Approved

Datasheet & Documentation

Request for DMF
DMF (Drug Master File)

Related Products

New Product Launch

Questions & Comments

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message